COVID-19 and mental health: A look at the pandemic’s impact on mental health, how we’re treating it, and how it’s affecting those in clinical trials [whitepaper]

In the past year, we’ve all been witness to an extraordinary amount of loss. We stayed away from family and friends, suffered unemployment and financial hardship, and cancelled even the most important plans — all while the COVID-19 death toll continued to tick up.

As the pandemic continues, there’s one question that continues to rise to the surface: how has this extended period of stress and loss impacted our mental health? Are we okay, and will we be in the future?

In this whitepaper, we take a look at the broad impact of COVID-19 on mental health. We focus first on the general public, then narrow in on people who tested positive, those with pre-existing mental health disorders, and healthcare workers. We explore mental health treatment during the pandemic, and dive into the implications for clinical trial participants as well.

Download our whitepaper to learn more.